The author treated as inpatients or outpatients a total of 26 individuals with typical acarophobia syndrome, using neuroleptics, mainly Pimozid/Orap. His results have shown that neuroleptics are drugs with rapid and pronounced action in acarophobia and that they have a syndrome-specific profile. The author presents the theoretical and practical consequences of his experiences in connection with this mode of treatment.